Muhammad Y. Ali

Family Medicine

360 Station Dr
Crystal Lake, IL 60014

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications.

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications.

Journal: World journal of urology

Published: May 26, 2026

Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials.

Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials.

Journal: The Lancet. Oncology

Published: February 06, 2026

Quality and Usability of Prostate Cancer Information Generated by Artificial Intelligence Chatbots: A Comparative Analysis.

Quality and Usability of Prostate Cancer Information Generated by Artificial Intelligence Chatbots: A Comparative Analysis.

Journal: Cancers

Published: February 04, 2026

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

Journal: The Lancet. Oncology

Published: December 20, 2025

Renal SABR: Implementation of A New Standard of Care.

Renal SABR: Implementation of A New Standard of Care.

Journal: International journal of radiation oncology, biology, physics

Published: September 26, 2025

Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma.

Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma.

Journal: BJU international

Published: June 28, 2025

International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiation Therapy.

International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: June 03, 2025

Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney.

Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney.

Journal: International journal of radiation oncology, biology, physics

Published: May 12, 2025

Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma.

Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma.

Journal: BMJ oncology

Published: March 20, 2025

PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study.

PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 01, 2024

Stereotactic ablative radiotherapy for primary kidney cancer - An international patterns of practice survey.

Stereotactic ablative radiotherapy for primary kidney cancer - An international patterns of practice survey.

Journal: Clinical and translational radiation oncology

Published: September 17, 2024

Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer.

Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer.

Journal: BJU international

Published: August 26, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026